Mérieux NutriSciences Blog

    PFAS in Pharmaceuticals
    Regulatory Updates | Pharmaceuticals
    20/04/2026

    PFAS in Pharmaceuticals: A Patient-Centered Approach to Regulation
    ICH Q1
    Regulatory Updates | Pharmaceuticals
    08/04/2026

    ICH Q1 (2025): Understanding the Shift in Pharmaceutical Stability Testing
    Passepartout Studies
    Packaging | Pharmaceuticals | Services
    25/03/2025

    Introducing Passepartout Studies: Versatile Extractables Profiling for Pharmaceutical Packaging
    Events | Pharmaceuticals
    02/05/2023

    Mérieux NutriSciences talks about Extractables & Leachables testing
    Alerts | Contaminants | Pharmaceuticals | Services
    22/12/2022

    Nitrosamine alerts: EMA never stops updating Q&A documents on nitrosamine impurities
    Pharmaceuticals | Services
    22/09/2022

    Behind the scenes with Orianna Marcon
    Pharmaceuticals | Services
    30/08/2022

    Behind the scenes with Enrico Ferraro and Margherita Monico
    Pharmaceuticals | Services
    25/08/2022

    Behind the scenes with Federica Licitra and Veronica Poletti
    Webinar Nitrosammine website
    Events | Pharmaceuticals
    12/08/2022

    FREE WEBINAR – Enhancing nitrosamines analysis: A FOCUS ON COMPLEX NITROSAMINES (NDSRIs or NO-APIs)
    Cphi 2022_eng
    Events | Pharmaceuticals
    01/08/2022

    Mérieux NutriSciences @CPhIworldwide® 2022
    Scientific Writing Ecsin
    Pharmaceuticals
    11/07/2022

    Scientific writing: vegetal extracts as a replacement for statins to reduce cholesterol
    allerta-nitrosammine-15
    Alerts | Pharmaceuticals | Services
    22/06/2022

    Nitrosamine alerts: on 20 may 2022, EMA updated the Q&A documents on nitrosamine impurities
    scientific writing nanotechnologies
    Pharmaceuticals
    13/06/2022

    Scientific writing: Nanotechnology strategies for the insulin oral delivery
    extractables and leachebles case study #4
    Pharmaceuticals | Services
    24/05/2022

    Extractables & Leachables case study – Extractables study on filters for pharmaceutical manufacturing
    Extractables & Leachables case study - Extractables study on silicone tubing
    Pharmaceuticals
    07/04/2022

    Extractables & Leachables case study – Extractables study on silicone tubing used for drug products manufacturing
    allerta-nitrosammine-15
    Alerts | Pharmaceuticals | Regulatory Updates
    07/04/2022

    Nitrosamines alert: extended deadline to submit data on NDMA and other impurities in products containing azithromycin
    allerta-nitrosammine-15
    Alerts | Pharmaceuticals | Regulatory Updates
    18/02/2022

    Nitrosamines alerts: recall saga seems to be never ending
    Pharmaceuticals | Packaging
    18/02/2022

    Pharmaceutical packaging: Extractables & Leachables case study – inhalation products
    biossido di titanio
    Regulatory Updates | Pharmaceuticals
    24/01/2022

    The European Commission banned titanium dioxide as a food additive
    allerta-nitrosammine-15
    Alerts | Pharmaceuticals
    26/11/2021

    Nitrosamines alert: Potential for endogenous formation of NDSRIs (nitrosamine drug substance-related impurities)
    allerta-nitrosammine-15
    Alerts | Pharmaceuticals
    14/07/2021

    Nitrosamine alerts: EMA defined acceptance limit for N-nitrosomorpholine in pharmaceutical products
    allerta-nitrosammine-15
    Alerts | Pharmaceuticals | Services
    29/04/2021

    Nitrosamine alerts: new deadlines for sartans
    allerta-nitrosammine-15
    Alerts | Pharmaceuticals
    23/11/2020

    New presence of nitrosamines in antibacterial drugs based on rifampicin in EU and US
    allerta-nitrosammine-15
    Alerts | Pharmaceuticals
    27/03/2020

    Nitrosamines alert: update from the European medicines regulatory network